期刊文献+

奈达铂或顺铂联合5-氟尿嘧啶治疗鼻咽癌的随机对照研究 被引量:20

Nedaplatin or cisplatin combined with 5-fluorouracil for treatment of stage Ⅲ-Ⅳa nasopharyngeal carcinom:a randomized controlled study
原文传递
导出
摘要 目的 比较奈达铂联合5-氟尿嘧啶(5-Fu)与顺铂联合5-Fu诱导化疗治疗局部中晚期鼻咽癌的疗效和耐受性.方法 100例经病理组织学确诊的Ⅲ、Ⅳa期鼻咽癌患者随机分为奈达铂联合5-Fu组(NF组)和顺铂联合5-Fu组(PF组),每组50例.NF组:奈达铂30 mg/m2,静脉滴注,第1~3天 5-Fu 500 mg/m2,静脉滴注,第1~5天,每3周重复,连续应用2个疗程.PF组:顺铂30 mg/m2,静脉滴注,第1~3天 5-Fu 500 mg/m2,静脉滴注,第1~5天,每3周重复,连续应用2个疗程.采用x2检验比较两组患者的疗效和急性不良反应.结果 50例患者均可进行疗效评价,两组患者的临床资料比较无明显差别.NF组和PF组患者肿瘤全消各3例.NF组的有效率为86.0%,PF组为84.0%,两组差异无统计学意义(x2=0.078,P=0.779).PF组患者恶心、呕吐的发生率(88.0%)明显高于NF组(56.0%,x2=23.268,P=0.000) 两组患者外周血白细胞数、血小板数、谷丙转氨酶、尿素氮和肌酐异常的发生率比较,差异无统计学意义(P〉0.05).结论 奈达铂联合5-Fu是治疗局部中晚期鼻咽癌的有效方案,有效率与PF方案相似.在减少恶心、呕吐方面,奈达铂联合5-Fu有明显的优势. Objective To compare the efficacy and side effects of nedaplatin plus 5-fluorouracil (5-Fu) and cisplatin plus 5-Fu for treatment of stage Ⅲ-Ⅳa nasopharyngeal carcinoma (NPC).Methods A total of 100 patients with NPC proved by histopathology were divided into nedaplatin plus 5-Fu group ( NF group) and cisplatin plus 5-Fu group (PF group), 50 cases in each group.NF group:nedaplatin 30 mg/m2,d1-d3, 5-Fu 500 mg/m2 d1-d5, repeated every 3 weeks for2 cycles.PF group:cisplatin 30 mg/m2 d1-d3, 5-Fu 500 mg/m2 d1-d5, repeated every 3 weeks for 2 cycles.x2 test was used to compare the efficacy and sideeffects of the two groups.Results All the 100 cases were evaluable and their clinical data in the two groups were comparable.Six patients with complete response were observed, 3 cases in NF group and 3 in PF group.The overall response rates were 86.0% in NF group and 84.0% in PF group, with no significant difference (x2 = 0.078, P = 0.779 ).The rates of leukocytopenia, thrombocytopenia, impairment of hepatic and renal function were similar whereas more patients in the PF group than in the NF group suffered from nausea and vomiting ( 88.0% vs.56.0%, P = 0.000).Conclusions Nedaplatin plus 5-Fu is an effective treatment regimen for NPC.When compared with PF regimen, the response rate is similar.However, NF regimen shows a significant superiority in reducing nausea and vomiting.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2011年第1期50-52,共3页 Chinese Journal of Oncology
基金 基金项目:“十一五”国家科技重大专项(2008zx09312-002)
关键词 鼻咽肿瘤 药物疗法 奈达铂 顺铂 Nasopharyngeal neoplasms Drug therapy Nedaplatin Cisplatin
  • 相关文献

参考文献7

二级参考文献65

  • 1管忠震,徐瑞华.奈达铂临床研究进展[J].中国肿瘤临床,2004,31(13):774-780. 被引量:176
  • 2张频,冯奉仪,吴令英,胡毅,刘基崴,高亚杰,关晓倩,南克俊,索爱莉,王秀问,张茂宏,张文东,李朝午,张阳,赵金波.奈达铂治疗恶性肿瘤的临床研究[J].中华肿瘤杂志,2006,28(3):230-234. 被引量:62
  • 3李苏宜,孙新臣,刘琳.食管癌内科治疗及综合治疗进展[J].癌症,2006,25(4):509-515. 被引量:25
  • 4徐瑞华,史艳侠,管忠震,姜文奇,黄河,马智勇,王建华,胡晓桦,谢伟敏,李星庚,刘亚利,潘良熹,戴爱娣,庄武,张春.国产奈达铂治疗食管癌的Ⅱ期临床试验报告[J].癌症,2006,25(12):1565-1568. 被引量:44
  • 5Zhao KL, Liu G, Jiang GL, et al. Association of haemoglobin level with morbidity and mortality of patients with locally advanced oesophageal carcinoma undergoing radiotherapy-secondary analysis of three consecutive clinical phase Ⅲ trials [ J ]. Clin Oncol (R Coil Radiol), 2006,18 ( 8 ) : 621-627.
  • 6Lin Q, Gao XS, Qiao XY, et al. Phase Ⅰ trial of escalating-dose cisplatin with 5-fluorouracil and concurrent radiotherapy in Chinese patients with esophageal cancer [ J]. Acta Med Okayama, 2008,62 ( 1 ) : 37-44.
  • 7Minamide J, Aoyama N, Takada K, et al. Evaluation of docetaxel, CDDP and 5-FU combined therapy as second- line chemotherapy for esophagus cancer [ J ]. Gan To Kagaku Ryoho, 2007,34( 1 ) :49-52.
  • 8Ajani JA, Moiseyenko VM, Tjulandin S, et al. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase Ⅲ trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group [J]. J Clin Oncol, 2007, 25(22):3210-3216.
  • 9Enzinger PC, Ryan DP, Clark JW, et al. Weekly docetaxel, cisplatin, and irinotecan (TPC) : results of a muhicenter phase Ⅱ trial in patients with metastatic esophagogastrie cancer [ J ]. Ann Oncol, 2009,20 (3):475-480.
  • 10Ilson DH. New developments in the treatment of esophageal cancer [ J]. Clin Adv Hematol Oncol, 2004, 2(2) :97-104.

共引文献228

同被引文献202

引证文献20

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部